Destiny Wealth Partners, LLC Eli Lilly & CO Transaction History

Destiny Wealth Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$321.55 - $374.67 $14,469 - $16,860	45 Added 97.83%	91 $0
Q2 2022 Jul 15, 2022	SELL	$278.73 - $327.27 $82,782 - $97,199	-297 Reduced 86.59%	46 $15,000
Q1 2022 Apr 21, 2022	BUY	$234.69 - $291.66 $74,866 - $93,039	319 Added 1329.17%	343 $98,000
Q3 2021 Oct 28, 2021	BUY	$221.6 - $272.71 $5,318 - $6,545	24 New	24 $6,000
Q2 2021 Jul 27, 2021	SELL	$180.55 - $233.54 $48,206 - $62,355	-267 Closed	0 $0
Q1 2021 Apr 22, 2021	SELL	$164.32 - $212.72 $267,512 - $346,308	-1,628 Reduced 85.91%	267 $50,000
Q4 2020 Feb 05, 2021	BUY	$130.46 - $172.63 $247,221 - $327,133	1,895 New	1,895 $320,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.